Stay updated on Pembrolizumab in Advanced Head and Neck Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Head and Neck Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Head and Neck Clinical Trial page
- Check3 days agoChange DetectedNew trial sites were added across multiple countries (including the US, Argentina, Hungary, Japan, the UK, Poland, Russia, South Korea, and others) and several existing sites were removed, reflecting a revised geographic footprint for NCT03765918. This update changes where participants can enroll and where data collection will occur.SummaryDifference0.6%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page’s footer revision label was updated from **v3.5.2** to **v3.5.3**, reflecting a software/version rollout rather than a change to the clinical trial record.SummaryDifference0.0%

- Check31 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.0%

- Check53 days agoChange DetectedAdded a Results and Publications section with the NEJM publication and associated outcomes.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision label updated to v3.5.0 (previously v3.4.3).SummaryDifference0.0%

- Check68 days agoChange DetectedRevision updated to v3.4.3; previous revision v3.4.2 was removed.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab in Advanced Head and Neck Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Head and Neck Clinical Trial page.